LabCorp to Buy Genzyme Genetics for $925M | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Laboratory Corporation of American Holdings today announced a definitive agreement to purchase Genzyme Genetics for $925 million in an all-cash deal.

LabCorp will purchase the Genetics segment in its entirety, including all testing services, technology, intellectual property rights, and its nine testing laboratories. LabCorp is "committed" to offer employment to all of Genzyme Genetics' approximately 1,900 employees, including senior management, Genzyme said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Being born premature shouldn't mean infants with high blood sugar levels don't undergo genetic testing for neonatal diabetes, a study in Pediatrics says.

In Cell this week: phosphoproteomic patterns in prostate cancer, effect of gene expression on fitness in yeast, and more.

Scripps Research Institute investigators peer back at the RNA world.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.